Pharmaceutical

Encare’s ERAS Interactive Audit System (EIAS) has earned qualification on the Mayo Clinic Platform_Solutions Studio – a distinction rarely awarded to...

Eli Lilly reported that all three doses of its oral GLP-1 orforglipron helped patients who are obese or overweight with Type 2 diabetes achieve “signi...

Nusano, a privately held physics company that specializes in making medical radioisotopes, cut the ribbon at a much-needed manufacturing plant in Utah...

Weeks after telegraphing a series of upgrades to its Mexico operations over the next five years, Bayer is rolling up its sleeves with plans to overhau...

Pfizer is laying off 100 employees in Bothell, Washington, which used to host Seagen’s global headquarters.

Eight months after Sanofi’s former Chief Medical Officer, Dietmar Berger, M.D., departed, the French drugmaker has selected a successor.

Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown for the first time that it can extend patients’ lives. The resu...

Faster review times could leave drugmakers vulnerable to litigation, while new Trump administration priorities add more uncertainty to the drug approv...

Stealth secured a new agency review of its experimental therapy elamipretide after a rejection this year. The result could carry broader consequences.

Cemdisiran helped control symptoms of generalized myasthenia gravis, but combination treatment with a Regeneron antibody didn't appear as effective.